Catherine Copeland

1.3k total citations
29 papers, 943 citations indexed

About

Catherine Copeland is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Catherine Copeland has authored 29 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 11 papers in Epidemiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Catherine Copeland's work include Transplantation: Methods and Outcomes (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Catherine Copeland is often cited by papers focused on Transplantation: Methods and Outcomes (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Catherine Copeland collaborates with scholars based in United States, United Kingdom and India. Catherine Copeland's co-authors include Scott M. Palmer, Laurie D. Snyder, David M. Vock, W. Austin Davis, Jamie L. Todd, Elizabeth N. Pavlisko, Annette L. Fitzpatrick, David C. Atkins, Janice F. Bell and David Zaas and has published in prestigious journals such as Blood, Annals of Internal Medicine and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Catherine Copeland

29 papers receiving 935 citations

Peers

Catherine Copeland
Michael R. Mill United States
Edward A. Rose United States
Jane Cassidy United Kingdom
Thomas R. McCune United States
Shashank Desai United States
Michael R. Mill United States
Catherine Copeland
Citations per year, relative to Catherine Copeland Catherine Copeland (= 1×) peers Michael R. Mill

Countries citing papers authored by Catherine Copeland

Since Specialization
Citations

This map shows the geographic impact of Catherine Copeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Copeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Copeland more than expected).

Fields of papers citing papers by Catherine Copeland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Copeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Copeland. The network helps show where Catherine Copeland may publish in the future.

Co-authorship network of co-authors of Catherine Copeland

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Copeland. A scholar is included among the top collaborators of Catherine Copeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Copeland. Catherine Copeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todd, Jamie L., Megan L. Neely, Catherine Copeland, et al.. (2018). Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation. 38(2). 184–193. 8 indexed citations
2.
Snowden, Mark, Lesley Steinman, Lucinda L. Bryant, et al.. (2017). Dementia and co‐occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?. International Journal of Geriatric Psychiatry. 32(4). 357–371. 61 indexed citations
3.
Todd, Jamie L., Catherine Copeland, Megan L. Neely, & Scott M. Palmer. (2016). FVC and FEV1 Decline in Chronic Lung Allograft Dysfunction (CLAD) Phenotypes. The Journal of Heart and Lung Transplantation. 35(4). S223–S224. 1 indexed citations
4.
Derhovanessian, Ariss, Jamie L. Todd, Alice Zhang, et al.. (2016). Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients. Annals of the American Thoracic Society. 13(5). 627–635. 38 indexed citations
5.
Vock, David M., Michael T. Durheim, Wayne Tsuang, et al.. (2016). Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation. Annals of the American Thoracic Society. 14(2). 172–181. 86 indexed citations
6.
Copeland, Catherine, et al.. (2016). Antibody depletion strategy for the treatment of suspected antibody‐mediated rejection in lung transplant recipients: Does it work?. Clinical Transplantation. 31(3). 22 indexed citations
7.
Snyder, Laurie D., Cliburn Chan, John S. Yi, et al.. (2015). Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation. American Journal of Respiratory and Critical Care Medicine. 193(1). 78–85. 68 indexed citations
8.
Todd, Jamie L., Elizabeth N. Pavlisko, Catherine Copeland, et al.. (2014). Impact of Forced Vital Capacity Loss on Survival after the Onset of Chronic Lung Allograft Dysfunction. American Journal of Respiratory and Critical Care Medicine. 189(2). 159–166. 100 indexed citations
9.
Snowden, Mark, David C. Atkins, Lesley Steinman, et al.. (2014). Longitudinal Association of Dementia and Depression. American Journal of Geriatric Psychiatry. 23(9). 897–905. 88 indexed citations
10.
Copeland, Catherine, David M. Vock, Karen S. Pieper, Daniel B. Mark, & Scott M. Palmer. (2013). Impact of Lung Transplantation on Recipient Quality of Life. CHEST Journal. 143(3). 744–750. 55 indexed citations
11.
Vock, David M., Anastasios A. Tsiatis, Marie Davidian, et al.. (2013). Assessing the Causal Effect of Organ Transplantation on the Distribution of Residual Lifetime. Biometrics. 69(4). 820–829. 12 indexed citations
12.
Kelly, Francine L., Vanessa E. Kennedy, Raksha Jain, et al.. (2012). Epithelial Clara Cell Injury Occurs in Bronchiolitis Obliterans Syndrome After Human Lung Transplantation. American Journal of Transplantation. 12(11). 3076–3084. 46 indexed citations
13.
Chou, Joanne F., Nancy A. Kernan, Susan E. Prockop, et al.. (2011). Safety and Immunogenicity of the Live Attenuated Varicella Vaccine Following T Replete or T Cell-Depleted Related and Unrelated Allogeneic Hematopoietic Cell Transplantation (alloHCT). Biology of Blood and Marrow Transplantation. 17(11). 1708–1713. 34 indexed citations
14.
Davis, Wendy A., et al.. (2011). Spirometrically Significant Acute Rejection Increases the Risk for BOS and Death After Lung Transplantation. American Journal of Transplantation. 12(3). 745–752. 38 indexed citations
15.
Snyder, Laurie D., et al.. (2011). Is Prevention the Best Treatment? CMV After Lung Transplantation. American Journal of Transplantation. 12(3). 539–544. 25 indexed citations
16.
Copeland, Catherine, et al.. (2010). Survival after Bronchiolitis Obliterans Syndrome among Bilateral Lung Transplant Recipients. American Journal of Respiratory and Critical Care Medicine. 182(6). 784–789. 108 indexed citations
17.
Small, Trudy N., Nancy A. Kernan, Susan E. Prockop, et al.. (2009). Immunogenicity of the Live Attenuated Varicella Vaccine Following Allogeneneic HCT.. Blood. 114(22). 1137–1137. 2 indexed citations
18.
Mahler, Michelle, Nancy A. Kernan, Farid Boulad, et al.. (2008). Immunogenicity of the Tetravalent Protein-Conjugated Meningococcal Vaccine in Recipients of Related and Unrelated Allogeneic Hematopoietic Cell Transplants (HCT). Blood. 112(11). 1163–1163. 2 indexed citations
19.
Bahr, Raymond D., et al.. (2002). Chest pain centers--Part 2. The strategy of the chest pain center.. PubMed. 13(2). 21–2. 9 indexed citations
20.
Bahr, Raymond D., et al.. (2002). Chest pain centers--Part 1. Chest pain centers: past, present and future.. PubMed. 13(2). 19–20. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026